No mortality benefit of bypass surgery compared to latest generation of drug-coated stents

Newer drug-coated stents that keep arteries open have similar long-term rates of death compared with traditional bypass surgery for patients with more than one diseased coronary artery. Clinical practice in this area is still largely guided by past studies of bare-metal and first-generation drug-coated stents -- studies that found greater long-term risks of heart attack and death from the devices, compared to traditional bypass surgery.



from Today's Healthcare News -- ScienceDaily http://ift.tt/1wXqiGH